Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment (2012)
- Authors:
- Autor USP: HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1177/0269881112444941
- Subjects: ESQUIZOFRENIA (FISIOPATOLOGIA); ANTIBIÓTICOS; ANTIPSICÓTICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Psychopharmacology
- ISSN: 0269-8811
- Volume/Número/Paginação/Ano: v. 26, n. 9, p. 1185-1193, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CHAUDHRY, Imran B. et al. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. Journal of Psychopharmacology, v. 26, n. 9, p. 1185-1193, 2012Tradução . . Disponível em: https://doi.org/10.1177/0269881112444941. Acesso em: 18 fev. 2026. -
APA
Chaudhry, I. B., Hallak, J. E. C., Husain, N., Minhas, F., Stirling, J., Richardson, P., et al. (2012). Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. Journal of Psychopharmacology, 26( 9), 1185-1193. doi:10.1177/0269881112444941 -
NLM
Chaudhry IB, Hallak JEC, Husain N, Minhas F, Stirling J, Richardson P, Dursun S, Dunn G, Deakin B. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment [Internet]. Journal of Psychopharmacology. 2012 ; 26( 9): 1185-1193.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1177/0269881112444941 -
Vancouver
Chaudhry IB, Hallak JEC, Husain N, Minhas F, Stirling J, Richardson P, Dursun S, Dunn G, Deakin B. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment [Internet]. Journal of Psychopharmacology. 2012 ; 26( 9): 1185-1193.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1177/0269881112444941 - Psychotic syndrome secondary to meningioma treated with a low dose of olanzapine. [Carta]
- Sodium nitroprusside for schizophrenia. [Carta]: could methodological variables account for the different results obtained ?
- Disorganized symptoms predicted worse functioning outcome in schizophrenia patients with established illness
- Transtorno de pânico e outros medicamentos
- Psychedelics and Personality
- Nitric oxide’s involvement in the spectrum of psychotic disorders
- Effects of the natural β-carboline alkaloid harmine, a main constituent of Ayahuasca, in memory and in the hippocampus: a systematic literature review of preclinical studies
- An overview of animal models related to schizophrenia
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
- Cognition in at-risk mental states for psychosis
Informações sobre o DOI: 10.1177/0269881112444941 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
